These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 29067992)

  • 1. Medical cannabis for the treatment of chronic pain and other disorders: misconceptions and facts.
    Hill KP; Palastro MD
    Pol Arch Intern Med; 2017 Nov; 127(11):785-789. PubMed ID: 29067992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
    Krcevski-Skvarc N; Wells C; Häuser W
    Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.
    Hill KP
    JAMA; 2015 Jun 23-30; 313(24):2474-83. PubMed ID: 26103031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MEDICAL CANNABIS].
    Naftali T
    Harefuah; 2016 Feb; 155(2):79-82, 133. PubMed ID: 27215115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis and Cannabinoids for Chronic Pain.
    Romero-Sandoval EA; Kolano AL; Alvarado-Vázquez PA
    Curr Rheumatol Rep; 2017 Oct; 19(11):67. PubMed ID: 28983880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis-based medicinal products: summary of NICE guidance.
    Chang-Douglass S; Mulvihill C; Pilling S;
    BMJ; 2020 Apr; 369():m1108. PubMed ID: 32317246
    [No Abstract]   [Full Text] [Related]  

  • 8. Cannabis for Chronic Pain: Challenges and Considerations.
    Romero-Sandoval EA; Fincham JE; Kolano AL; Sharpe BN; Alvarado-Vázquez PA
    Pharmacotherapy; 2018 Jun; 38(6):651-662. PubMed ID: 29637590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical cannabis: A forward vision for the clinician.
    Fitzcharles MA; Eisenberg E
    Eur J Pain; 2018 Mar; 22(3):485-491. PubMed ID: 29377381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews.
    Häuser W; Petzke F; Fitzcharles MA
    Eur J Pain; 2018 Mar; 22(3):455-470. PubMed ID: 29034533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis and multiple sclerosis.
    Fragoso YD; Carra A; Macias MA
    Expert Rev Neurother; 2020 Aug; 20(8):849-854. PubMed ID: 32515670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical use of cannabis in Switzerland: analysis of approved exceptional licences.
    Kilcher G; Zwahlen M; Ritter C; Fenner L; Egger M
    Swiss Med Wkly; 2017; 147():w14463. PubMed ID: 28695562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cannabis paradox.
    Ladouceur R
    Can Fam Physician; 2018 Feb; 64(2):86. PubMed ID: 29449225
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of medical-grade cannabis in patients non-responders to Nabiximols.
    Saccà F; Pane C; Carotenuto A; Massarelli M; Lanzillo R; Florio EB; Brescia Morra V
    J Neurol Sci; 2016 Sep; 368():349-51. PubMed ID: 27538663
    [No Abstract]   [Full Text] [Related]  

  • 15. [There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis].
    Basinski H; Jensen HB; Stenager E
    Ugeskr Laeger; 2014 Mar; 176(12A):. PubMed ID: 25350886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
    Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
    Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline.
    Busse JW; Vankrunkelsven P; Zeng L; Heen AF; Merglen A; Campbell F; Granan LP; Aertgeerts B; Buchbinder R; Coen M; Juurlink D; Samer C; Siemieniuk RAC; Kumar N; Cooper L; Brown J; Lytvyn L; Zeraatkar D; Wang L; Guyatt GH; Vandvik PO; Agoritsas T
    BMJ; 2021 Sep; 374():n2040. PubMed ID: 34497062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
    Weinkle L; Domen CH; Shelton I; Sillau S; Nair K; Alvarez E
    Mult Scler Relat Disord; 2019 Jan; 27():383-390. PubMed ID: 30502644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
    Whiting PF; Wolff RF; Deshpande S; Di Nisio M; Duffy S; Hernandez AV; Keurentjes JC; Lang S; Misso K; Ryder S; Schmidlkofer S; Westwood M; Kleijnen J
    JAMA; 2015 Jun 23-30; 313(24):2456-73. PubMed ID: 26103030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids in Neurologic Illnesses.
    Patel AD
    Neurol Clin; 2021 Feb; 39(1):231-241. PubMed ID: 33223086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.